在用本拉利祖马布控制的严重乙酸性喘中,逐渐减少高剂量的ICS剂量,同时保持控制
1Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada (M.B.S.).
Annals of internal medicine
|April 1, 2024
概括
贝纳利祖马布显著降低了每天吸入的皮质类固醇的需要在严重的酸性喘患者. 这种生物疗法提供了一种潜在的途径,可以降低严重喘管理中的皮质类固醇依赖.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的乙酸性喘通常与频繁的恶化和依赖高剂量吸入性皮质类固醇 (ICS) 相关.
- 减少ICS负担至关重要,以尽量减少长期副作用,同时保持喘控制.
- 贝纳利祖马布是一种针对eosinophilic炎症的互白素-5受体α对抗剂.
研究的目的:
- 评价每日维持ICS剂量减少的可行性和有效性,在治疗本拉利祖马布的重症埃索诺菲尔性喘患者.
- 评估ICS减少对喘控制,恶化和肺功能的影响.
主要方法:
- 一个随机的,多中心的,开放的,第四阶段研究 (SHAMAL) 涉及患有严重酸性喘的患者.
- 参与者接受了本拉利祖马布,并接受了一项结构化的方案,以减少日常维护ICS.
- 主要终点包括患者实现ICS减轻并保持喘控制的比例.
主要成果:
- 在接受本拉利祖马布治疗期间,很大一部分患者成功降低了每日ICS维持剂量.
- 贝纳利祖马布治疗与持续控制喘和减少ICS减少期间恶化率有关.
- 在接受ICS缩小治疗的患者中没有观察到肺功能显著下降.
结论:
- 本拉利祖马布有助于在患有严重酸性喘的患者中减少每日维护ICS.
- 这种方法可能有助于减轻ICS相关的并发症,并改善患者的生活质量.
- 贝纳利祖马布代表了一种有价值的治疗选择,用于管理严重的酸性喘,并使ICS降级.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
243
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
243
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
01:19Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
261
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
261
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
437
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
437